App Note: The Chiral Separation of Remdesivir and Several of its Key-Starting Materials - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    App Note: The Chiral Separation of Remdesivir and Several of its Key-Starting Materials

    Article obtained from LCGC Liquid Chromatography (LC/HPLC) RSS Feed.

    This application note shares new chiral separations for the anti-viral, COVID-19 treatment Remdesivir and its phosphoramidite and nucleoside key-starting materials.

    READ MORE
    May, 13 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.